{
    "organizations": [],
    "uuid": "39849d474a11be7fe6e8ca7e453879566c365d97",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-uniqure-q1-revenue-35-mln-vs-i-b-e/brief-uniqure-q1-revenue-3-5-mln-vs-i-b-e-s-view-2-8-mln-idUSASC09Y6T",
    "ord_in_thread": 0,
    "title": "Uniqure Q1 Revenue $3.5 Mln Vs I/B/E/S View $2.8 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30, 2018 / 11:55 AM / Updated 21 minutes ago BRIEF-Uniqure Q1 Revenue $3.5 Mln Vs I/B/E/S View $2.8 Mln Reuters Staff\nApril 30 (Reuters) - Uniqure NV:\n* UNIQURE ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS COMPANY PROGRESS * Q1 REVENUE $3.5 MILLION VERSUS I/B/E/S VIEW $2.8 MILLION\n* Q1 EARNINGS PER SHARE VIEW $-0.74 — THOMSON REUTERS I/B/E/S\n* IND FILING FOR AMT-130 IN HUNTINGTON’S DISEASE EXPECTED IN SECOND HALF OF 2018\n* PATIENT ENROLLMENT EXPECTED TO BEGIN AHEAD OF SCHEDULE IN DOSE-CONFIRMATION STUDY FOR AMT-061\n* AMT-061 PIVOTAL STUDY ON TRACK TO COMMENCE IN Q3 OF 2018\n* CURRENTLY EXPECTS CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO EARLY 2020 Source text for Eikon: Further company coverage:",
    "published": "2018-04-30T19:55:00.000+03:00",
    "crawled": "2018-04-30T15:09:52.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "q1",
        "revenue",
        "mln",
        "v",
        "view",
        "mln",
        "reuters",
        "staff",
        "april",
        "reuters",
        "uniqure",
        "nv",
        "uniqure",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "highlight",
        "company",
        "progress",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "ind",
        "filing",
        "huntington",
        "disease",
        "expected",
        "second",
        "half",
        "patient",
        "enrollment",
        "expected",
        "begin",
        "ahead",
        "schedule",
        "study",
        "pivotal",
        "study",
        "track",
        "commence",
        "q3",
        "currently",
        "expects",
        "cash",
        "cash",
        "equivalent",
        "sufficient",
        "fund",
        "operation",
        "early",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}